Meeting Highlights Information Registration Visa Letter Application Programme Overview Exhibition Virtual Exhibition Hotels Exhibition Virtual Exhibition Satellite Programme


Search Abstracts by author or title
(results will display both Free Papers & Poster)

First results of implantation of the small-aperture intraocular lens binocularly

Session Details

Session Title: Cataract
Session Date/Time: Friday 21/02/2020 | 10:30-13:00
Paper Time: 11:54
Venue: Fes 1.

First Author: M.Rau GERMANY
Co Author(s):                  

Abstract Details

Purpose:

To evaluate optical and functional outcomes and patients satisfaction after Implantation of a Small-Aperture IC-8 IOL  binocularly.

Setting:

Augenklinik Cham Germany

Methods:

In a prospective case study from September 2018-January 2019 a series of 10 patients, presenting for cataract surgery, were implanted bilaterally with a single-piece hydrophobic acrylic intraocular with a centrally located opaque annular mask measuring 3.23 mm in total diameter with a 1.36 mm central aperture. The visual acuity for distance, intermediate and near vision  was evaluated. The quality of vision, glare, halos and the personal satisfaction of the patients was assessed with a validated questionnaire.

Results:

Three months after the Implantation the mean UCVA for distance was monocular 0,78, binocular  0,89 for intermediate monocular  071, binocular  0,76,for near vision monocular  0,58, binocular 0,63. The mean refraction was -0,35D None of the patients needed glasses for working on  PC ,  76 % were able to read newspaper without glasses. The questionnaire showed, that 30% of the patients were very satisfied  and 70% satisfied with the achieved results, nobody complained about halos and glares.

Conclusions:

Early optical and functional results from patients implanted  with this novel IOL implanted bilateral show, that IC 8 implanted bilateral provides an excellent visual acuity for distance, intermediate and very good near vision. Overall patient satisfaction was high.

Financial Disclosure:

 

Back to previous